共 50 条
- [7] A Phase III Randomized Equivalence Study of Biosimilar Filgrastim versus Amgen Filgrastim in Patients Receiving Myelosuppressive Chemotherapy for Breast Cancer ONKOLOGIE, 2010, 33 (10): : 504 - 511
- [9] A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel ONCOLOGIST, 2016, 21 (01): : 7 - 15